Anthony Zietman
Anthony Zietman
Professor of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial
AL Zietman, ML DeSilvio, JD Slater, CJ Rossi, DW Miller, JA Adams, ...
Jama 294 (10), 1233-1239, 2005
Early detection of prostate cancer: AUA Guideline
HB Carter, PC Albertsen, MJ Barry, R Etzioni, SJ Freedland, KL Greene, ...
The Journal of urology 190 (2), 419-426, 2013
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation …
AL Zietman, K Bae, JD Slater, WU Shipley, JA Efstathiou, JJ Coen, ...
Journal of clinical oncology 28 (7), 1106, 2010
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer
MR Smith, FJ McGovern, AL Zietman, MA Fallon, DL Hayden, ...
New England Journal of Medicine 345 (13), 948-955, 2001
Changes in body composition during androgen deprivation therapy for prostate cancer
MR Smith, JS Finkelstein, FJ McGovern, AL Zietman, MA Fallon, ...
The Journal of Clinical Endocrinology & Metabolism 87 (2), 599-603, 2002
Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline
SS Chang, BH Bochner, R Chou, R Dreicer, AM Kamat, SP Lerner, ...
The Journal of urology 198 (3), 552-559, 2017
Prostate specific antigen best practice statement: 2009 update
KL Greene, PC Albertsen, RJ Babaian, HB Carter, PH Gann, M Han, ...
The Journal of urology 189 (1), S2-S11, 2013
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results …
P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ...
BJU international 109, 22-29, 2012
Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation
MJ Zelefsky, DA Kuban, LB Levy, L Potters, DC Beyer, JC Blasko, ...
International Journal of Radiation Oncology* Biology* Physics 67 (2), 327-333, 2007
Radiation with or without antiandrogen therapy in recurrent prostate cancer
WU Shipley, W Seiferheld, HR Lukka, PP Major, NM Heney, DJ Grignon, ...
New England Journal of Medicine 376 (5), 417-428, 2017
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis
WU Shipley, HD Thames, HM Sandler, GE Hanks, AL Zietman, CA Perez, ...
Jama 281 (17), 1598-1604, 1999
Outcomes of localized prostate cancer following conservative management
GL Lu-Yao, PC Albertsen, DF Moore, W Shih, Y Lin, RS DiPaola, MJ Barry, ...
Jama 302 (11), 1202-1209, 2009
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer
FJ Fowler Jr, MMN Collins, PC Albertsen, A Zietman, DB Elliott, MJ Barry
Jama 283 (24), 3217-3222, 2000
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy
BJ Davis, EM Horwitz, WR Lee, JM Crook, RG Stock, GS Merrick, ...
Brachytherapy 11 (1), 6-19, 2012
Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation …
WU Shipley, LJ Verhey, JE Munzenrider, HD Suit, MM Urie, PL McManus, ...
International Journal of Radiation Oncology* Biology* Physics 32 (1), 3-12, 1995
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
HA Gay, HJ Barthold, E O’Meara, WR Bosch, I El Naqa, R Al-Lozi, ...
International Journal of Radiation Oncology* Biology* Physics 83 (3), e353-e362, 2012
Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer
WU Shipley, DS Kaufman, E Zehr, NM Heney, SC Lane, HK Thakral, ...
Urology 60 (1), 62-67, 2002
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience
JA Efstathiou, DY Spiegel, WU Shipley, NM Heney, DS Kaufman, ...
European urology 61 (4), 705-711, 2012
Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology …
RH Mak, D Hunt, WU Shipley, JA Efstathiou, WJ Tester, MP Hagan, ...
Journal of Clinical Oncology 32 (34), 3801, 2014
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
JM Michalski, C Lawton, I El Naqa, M Ritter, E O'Meara, MJ Seider, ...
International Journal of Radiation Oncology* Biology* Physics 76 (2), 361-368, 2010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20